Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

1.70
Delayed Data
As of 3:59pm ET
 +0.1579 / +10.25%
Today’s Change
1.10
Today|||52-Week Range
7.22
-54.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues73.7M14.3M14.7M17.9M
 
 
 
 
 
Cost of Goods Sold49.1M10.6M11.6M13.8M
 
 
 
 
 
Depreciation And Amortization9.0M1.6M1.6M2.2M
 
 
 
 
 
 
Operating ExpensesGross Income15.6M2.2M1.5M2.0M
 
 
 
 
 
General Expenses50.7M32.6M38.3M59.7M
 
 
 
 
 
Research And Development10.9M10.4M16.9M29.1M
 
 
 
 
 
Total Operating Expenses108.8M44.7M51.5M75.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.1M-30.4M-36.8M-57.7M
 
 
 
 
 
Extraordinary Credit2.3M0.0078.0K3.1M
 
 
 
 
Extraordinary Charge-19.4M-4.3M-1.9M--
 
 
 
 
Interest Expense On Debt4.0M1.6M281.4K755.7K
 
 
 
 
 
Other Expenses0.000.00207.1K-154.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-56.2M-36.3M-38.7M-55.6M
 
 
 
 
 
Income Taxes-392.8K-175.5K-780.1K-104.2K
 
 
 
 
 
Minority Interest-9.4M-287.2K-504.1K-593.3K
 
 
 
 
 
Preferred Dividend-639.8K-528.0K0.000.00
 
 
 
Discontinued Operations0.00-18.0M0.000.00
 
 
Net Income-47.1M-54.8M-39.0M-54.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.9M13.8M20.5M32.8M
 
 
 
 
 
Shares To Calculate EPS Diluted8.9M13.8M20.5M32.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.40-$4.00-$1.90-$1.68
 
 
 
 
 
EPS Diluted-$5.40-$4.00-$1.90-$1.68